Key Highlights
- On April 20, BWX Technologies revealed plans to purchase Precision Components Group (PCG), a domestic producer of sophisticated heavy-walled and heat-transfer components.
- The transaction brings more than 500,000 square feet of U.S. heavy-manufacturing space along with a workforce exceeding 400 employees into BWXT’s operations.
- PCG recorded approximately $125 million in sales during the previous year and will become part of BWXT’s Commercial Operations division.
- BWXT surpassed Q4 projections delivering EPS of $1.08 compared to the forecasted $0.91, while revenue reached $885.8M against the anticipated $837.5M, alongside FY2026 guidance projecting $4.55–$4.70 EPS.
- Institutional stakeholders control approximately 94.39% of shares, with Alkeon and Invesco expanding positions recently, whereas company insiders divested around 13,327 units totaling $2.73M during the past 90 days.
BWX Technologies (NYSE: BWXT) has unveiled a strategic acquisition targeting Precision Components Group to strengthen its position in the commercial nuclear sector.
The acquisition, revealed on April 20, encompasses PCG along with its operating units — Precision Custom Components and DC Fabricators — which will integrate into BWXT’s corporate structure. PCG will become part of BWXT’s Commercial Operations division while maintaining operations at its current locations.
According to BWXT leadership, the transaction secures over 500,000 square feet of domestic heavy-manufacturing infrastructure. The deal also incorporates a team of more than 400 experienced professionals.
PCG recorded approximately $125 million in annual sales during the preceding fiscal year, representing a substantial addition to BWXT’s revenue stream. Company executives position this acquisition as an initial phase in expanding domestically-based commercial nuclear manufacturing capabilities.
John MacQuarrie, President of Commercial Operations at BWXT, described the acquisition as advancing BWXT’s “strong performance in the commercial nuclear industry” while addressing what he characterized as “the accelerating needs of US commercial nuclear customers.”
Robust Financial Performance Supports Expansion
BWXT entered this acquisition from a position of financial strength. The company exceeded Wall Street projections during its latest reporting period, delivering EPS of $1.08 versus the anticipated $0.91 consensus. Revenue totaled $885.8 million, surpassing the $837.5 million forecast.
This revenue represented an 18.7% increase compared to the prior year, while full-year 2025 results showed total revenue climbing 18% to reach $3.19 billion. EPS expanded 20% during this timeframe with net margin reaching 10.3%.
Looking ahead to FY2026, management has established EPS guidance ranging from $4.55 to $4.70. Wall Street analysts maintain a consensus “Moderate Buy” recommendation on shares with an average price target of $207.60.
BWXT shares began Friday’s session at $223.54, trading above the 50-day moving average of $211.42 and the 200-day moving average of $198.99. The stock trades within a 52-week range spanning $102.42 to $241.82 while commanding a market capitalization of $20.48 billion.
Management also implemented a modest dividend increase, raising the quarterly payout to $0.27 from $0.25, which translates to an annualized $1.08 and yields approximately 0.5%.
Institutional Investors Maintain Strong Presence
Institutional investors hold roughly 94.39% of outstanding BWXT shares. Multiple major investment firms expanded their holdings during recent reporting periods. Alkeon Capital Management increased its position by 163% during Q3, accumulating over 1.57 million shares valued near $291 million. Invesco boosted its stake by 60.1% to exceed 2.5 million units.
B. Metzler seel. Sohn & Co. AG established a new position during Q4, acquiring 9,481 shares worth approximately $1.64 million.
Company insiders have taken a different approach. Internal stakeholders sold roughly 13,327 shares totaling $2.73 million during the previous 90-day period. CAO Kevin James Gorman divested 1,344 shares in early March at an average price of $214.71. Corporate insiders currently hold about 0.60% of outstanding shares.
Regarding analyst coverage, Wells Fargo launched coverage with an “underweight” recommendation and $200 price objective. TD Cowen assigned a “buy” rating with a $230 target. Zacks elevated BWXT from “hold” to “strong-buy” during January.
BWXT maintains its position as the exclusive producer of naval nuclear reactors for American submarines and aircraft carriers, having manufactured more than 400 naval reactors beginning with the USS Nautilus.
